The therapeutic potential of somatostatin receptor ligands in the treatment of obesity and diabetes

By Boehm Bernhard O  

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 9, 2003-09 ,pp. : 1501-1509

Informa Healthcare

Access to resources Recommend Favorite

Inhibition of Protein Tyrosine Phosphatase 1B as a Potential Treatment of Diabetes and Obesity

By  

Current Pharmaceutical Design, Vol. 10, Iss. 28, 2004-11 ,pp. : 3481-3504

Bentham Science Publishers

Access to resources Recommend Favorite

Potential role of UGT pharmacogenetics in cancer treatment and prevention: focus on tamoxifen and aromatase inhibitors

By Lazarus Philip   Sun Dongxiao  

Drug Metabolism Reviews, Vol. 42, Iss. 1, 2010-02 ,pp. : 182-194

Informa Healthcare

Access to resources Recommend Favorite

Adipokines in the treatment of diabetes mellitus and obesity

By Catalán Victoria   Gómez-Ambrosi Javier   Rodríguez Amaia   Salvador Javier   Frühbeck Gema  

Expert Opinion on Pharmacotherapy, Vol. 10, Iss. 2, 2009-02 ,pp. : 239-254

Informa Healthcare

Access to resources Recommend Favorite

PTP1B inhibitors as potential therapeutics in the treatment of Type 2 diabetes and obesity

By Zhang Zhong-Yin   Lee Seung-Yub  

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 2, 2003-02 ,pp. : 223-233

Informa Healthcare

Access to resources Recommend Favorite